Notably, NAC/PPT also exhibited significant therapeutic effects in a mouse model of a spinal cord disease ALS, whereas neither NAC nor PEG-PCL-Tat alone showed any observable therapeutic benefits [29]. This evidence concerns the gene TAT and amyotrophic lateral sclerosis.